C. Brefel-Courbon And NotVoie orale

List of bibliographic references

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000206	S. Lesage [France] ; C. Condroyer [France] ; S. Klebe [France] ; A. Honore [France] ; F. Tison [France] ; C. Brefel-Courbon [France] ; A. Diirr [France] ; A. Brice [France]	IDENTIFICATION OF VPS35 MUTATIONS REPLICATED IN FRENCH FAMILIES WITH PARKINSON DISEASE
000362	V. Marchand-Pauvert [France] ; A. Gerdelat-Mas [France] ; F. Ory-Magne [France] ; F. Calvas [France] ; D. Mazevet [France] ; S. Meunier [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; M. Simonetta-Moreau [France]	Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease
000476	P. Payoux [France] ; C. Brefel-Courbon [France] ; F. Ory-Magne [France] ; W. Regragui [France] ; C. Thalamas [France] ; S. Balduyck [France] ; F. Durif [France] ; J. P. Azulay [France] ; F. Tison [France] ; O. Blin [France] ; J. P. Esquerre [France] ; O. Rascol [France]	Motor activation in multiple system atrophy and Parkinson disease: A PET study
000828	T. Slaoui [France] ; A. Mas-Gerdelat [France] ; F. Ory-Magne [France] ; O. Rascol [France] ; C. Brefel-Courbon [France]	La lévodopa modifie les seuils nociceptifs chez le patient parkinsonien
000882	A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France]	Levodopa raises objective pain threshold in Parkinson's disease : a Rill reflex study
000D39	Olivier Rascol [France] ; C. Brefel-Courbon [France] ; P. Payoux [France] ; J. Ferreira [Portugal]	The management of patients with early Parkinson's disease
001064	O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]	Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
001122	C. Brefel-Courbon [France]	Quelles stratégies médicamenteuses sont à conseiller à la phase évoluée de la maladie de Parkinson
001264	C. Brefel-Courbon ; O. Rascol	Scintigraphies cérébrales et syndromes parkinsoniens
001370	N. Abbas [France] ; C. B. Lücking [France] ; S. Ricard [France] ; A. Dürr [France] ; V. Bonifati [Italie] ; G. De Michele [Italie] ; S. Bouley [France] ; J. R. Vaughan [Royaume-Uni] ; T. Gasser [Allemagne] ; R. Marconi [Italie] ; E. Broussolle [France] ; C. Brefel-Courbon [France] ; B. S. Harhangi [Pays-Bas] ; B. A. Oostra [Pays-Bas] ; E. Fabrizio [Italie] ; G. A. Böhme [France] ; L. Pradier [France] ; N. W. Wood [Royaume-Uni] ; A. Filla [Italie] ; G. Meco [Italie] ; P. Denefle [France] ; Yves Agid [France] ; A. Brice [France]	A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe
001386	O. Rascol [France] ; C. Brefel-Courbon [France] ; O. Blin [France]	Pharmacologie clinique des dyskinésies induites par la L-dopa chez les malades parkinsoniens
001407	C. Brefel-Courbon [France] ; C. Thalamas [France] ; H. Peyro Saint Paul [France] ; J.-M. Senard [France] ; J.-L. Montastruc [France] ; O. Rascol [France]	α2-Adrenoceptor antagonists: A new approach to Parkinson's disease?
001448	J. L. Montastruc [France] ; M. Pelat [France] ; P. Verwaerde [France] ; C. Brefel-Courbon [France] ; M. A. Tran [France] ; O. Blin [France] ; O. Rascol [France] ; J. M. Senard [France]	Fluoxetine in orthostatic hypotension of Parkinson's disease : A clinical and experimental pilot study
001498	N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France]	Parkinson « plus » : Mouvements anormaux

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024